Abstract: Compounds of formula (1) wherein R1 represents a -C(R2)(R3)-[C(R4)(R5)]m-L-R6 group or -R7; and the preparation and the therapeutic uses of the compounds of formula (1) as agonists of TRPM8 receptors, useful especially in the treatment of oropharyngeal dysphagia.
| # | Name | Date |
|---|---|---|
| 1 | 202317046747-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [12-07-2023(online)].pdf | 2023-07-12 |
| 2 | 202317046747-STATEMENT OF UNDERTAKING (FORM 3) [12-07-2023(online)].pdf | 2023-07-12 |
| 3 | 202317046747-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [12-07-2023(online)].pdf | 2023-07-12 |
| 4 | 202317046747-FORM 1 [12-07-2023(online)].pdf | 2023-07-12 |
| 5 | 202317046747-DECLARATION OF INVENTORSHIP (FORM 5) [12-07-2023(online)].pdf | 2023-07-12 |
| 6 | 202317046747-COMPLETE SPECIFICATION [12-07-2023(online)].pdf | 2023-07-12 |
| 7 | 202317046747-FORM-26 [28-09-2023(online)].pdf | 2023-09-28 |
| 8 | 202317046747-FORM 3 [12-01-2024(online)].pdf | 2024-01-12 |
| 9 | 202317046747-FORM 18 [18-10-2024(online)].pdf | 2024-10-18 |
| 10 | 202317046747-Proof of Right [31-12-2024(online)].pdf | 2024-12-31 |